$532 Million is the total value of SECTOR GAMMA AS's 26 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 13.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Sell | LILLY ELI & CO | $49,062,000 | -19.5% | 667,050 | -19.1% | 9.23% | -13.4% |
| BAX | Sell | BAXTER INTL INC | $42,249,000 | -17.8% | 952,833 | -11.7% | 7.95% | -11.6% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $26,257,000 | -18.0% | 449,290 | -26.1% | 4.94% | -11.8% |
| GILD | Sell | GILEAD SCIENCES INC | $25,729,000 | -4.7% | 359,290 | -1.6% | 4.84% | +2.4% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $24,125,000 | +0.5% | 281,207 | -8.2% | 4.54% | +8.0% |
| MASI | Sell | MASIMO CORP | $21,096,000 | -2.1% | 313,004 | -12.1% | 3.97% | +5.3% |
| BIO | Sell | BIO RAD LABS INCcl a | $20,788,000 | -7.0% | 114,042 | -14.0% | 3.91% | -0.1% |
| MRK | Sell | MERCK & CO INC NEW | $16,684,000 | -12.6% | 283,410 | -10.9% | 3.14% | -6.1% |
| MCK | Sell | MCKESSON CORP | $16,180,000 | -8.6% | 115,200 | -12.5% | 3.04% | -1.8% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $12,872,000 | +20.9% | 855,265 | -10.8% | 2.42% | +30.0% |
| CI | Sell | CIGNA CORPORATION | $12,708,000 | -10.2% | 95,270 | -15.0% | 2.39% | -3.5% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $9,750,000 | -2.3% | 67,974 | -18.6% | 1.83% | +5.0% |
| EXEL | Sell | EXELIXIS INC | $7,755,000 | -61.0% | 520,091 | -67.7% | 1.46% | -58.1% |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -73,810 | -100.0% | -0.05% | – |
| BIIB | Exit | BIOGEN IDEC INC | $0 | – | -71,400 | -100.0% | -3.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.